The U.S. Centers for Medicare and Medicaid Services on Friday said it would not appeal a court order that it recalculate the ...
Trump’s executive order halts an effort to cap the copayment for generic medications at $2 for Medicare beneficiaries.
The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started ...
The General Enrollment Period provides an opportunity to make up for a past oversight — the failure to enroll in Part B.
This represents an expansion from the prior Medicare coverage of Guardant Reveal testing for CRC only in the early post-surgical setting. The tissue-free Guardant Reveal test uses a blood sample ...
The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started ...
NEW YORK – Guardant Health announced Tuesday that its Guardant Reveal liquid biopsy test has received coverage from Medicare administrative contractor Palmetto GBA to monitor colorectal cancer ...
Guardant Health has secured Medicare coverage from Palmetto for its blood test to monitor for disease recurrence in patients with colorectal cancer.
Shares of Guardant Health (NASDAQ:GH) have increased by 5.0% in premarket trading Tuesday following the company's ...
Despite online claims, President Donald Trump’s executive orders did not include removing Medicare’s $35 monthly out-of-pocket price cap, which is set by law.
Australia’s biggest bank, Commonwealth Bank (CBA), has teamed up with Services Australia to trial a new myGov verification ...